Advertisement
Home »

A cost-benefit analysis of mass prostate cancer screening.

May 06, 2024

ABOUT THE EXPERTS

  • Hiro Farabi

    Barts and the London Pragmatic Clinical Trials Unit, Centre for Evaluation and Methods, Wolfson Institute of Population Health, Queen Mary University of London, London, UK. h.farabi@qmul.ac.uk.

    Najmeh Moradi

    Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.

    Aziz Ahmadzadeh

    Insurance Research Center (IRC), Tehran, Iran.

    Seyed Mohammad Kazem Aghamir

    Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran.

    Abdolreza Mohammadi

    Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran.

    Aziz Rezapour

    Health Management and Economics Research Center, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement